Viktar Abashkin
Overview
Explore the profile of Viktar Abashkin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
High-density lipoprotein-like nanoparticles with cationic cholesterol derivatives for siRNA delivery
Ihnatsyeu-Kachan A, Sharko O, Bekish A, Saichuk A, Zhogla V, Abashkin V, et al.
Biomater Adv
. 2025 Feb;
170:214202.
PMID: 39923604
A new approach to siRNA delivery using high-density lipoprotein-like nanoparticles (HDL NPs) was investigated, incorporating oligoamine and cholesterol-derived cationic lipids (CLs) to associate siRNA with the carrier. Newly designed or...
2.
Padnya P, Shiabiev I, Pysin D, Gerasimova T, Ranishenka B, Stanavaya A, et al.
Int J Mol Sci
. 2024 Dec;
25(23).
PMID: 39684325
Cancer is one of the most common diseases in developed countries. Recently, gene therapy has emerged as a promising approach to cancer treatment and has already entered clinical practice worldwide....
3.
Mostovaya O, Shiabiev I, Ovchinnikov D, Pysin D, Mukhametzyanov T, Stanavaya A, et al.
Pharmaceutics
. 2024 Nov;
16(11).
PMID: 39598503
: Current promising treatments for many diseases are based on the use of therapeutic nucleic acids, including DNA. However, the list of nanocarriers is limited due to their low biocompatibility,...
4.
Shcharbin D, Zhogla V, Abashkin V, Gao Y, Majoral J, Mignani S, et al.
Wiley Interdiscip Rev Nanomed Nanobiotechnol
. 2024 Mar;
16(2):e1951.
PMID: 38456205
The application of nanotechnology in biological and medical fields have resulted in the creation of new devices, supramolecular systems, structures, complexes, and composites. Dendrimers are relatively new nanotechnological polymers with...
5.
Abashkin V, Pedziwiatr-Werbicka E, Horodecka K, Zhogla V, Ulashchik E, Shmanai V, et al.
Int J Mol Sci
. 2023 Jan;
24(1).
PMID: 36614277
The fact that cancer is one of the leading causes of death requires researchers to create new systems of effective treatment for malignant tumors. One promising area is genetic therapy...
6.
Mostovaya O, Shiabiev I, Pysin D, Stanavaya A, Abashkin V, Shcharbin D, et al.
Pharmaceutics
. 2022 Dec;
14(12).
PMID: 36559243
A convenient method for the synthesis of the second generation of PAMAM dendrimers based on a -butylthiacalix[4]arene core in , and conformations was developed. Unusual fluorescence of the obtained PAMAM-calix-dendrimers...
7.
Drinevskyi A, Zelkovskyi E, Abashkin V, Shcharbin D, Rysalskaya T, Radziuk D
ACS Biomater Sci Eng
. 2022 Dec;
9(1):182-196.
PMID: 36472577
An ultrasonic method (20 kHz) is introduced to activate pristine ibuprofen organic molecular crystals via complexation with silver in nitrogen-doped oxidized graphene nanoplatforms (∼50 nm). Ultrasonic complexation occurs in a...
8.
Mikhnavets L, Abashkin V, Khamitsevich H, Shcharbin D, Burko A, Krekoten N, et al.
ACS Biomater Sci Eng
. 2022 Feb;
8(3):1181-1192.
PMID: 35226462
We demonstrate a single-step ultrasonic in situ complexation of salicylic acid during the growth of FeO-reduced graphene oxide nanoparticles (∼10 nm) to improve the antioxidant and antiproliferative effects of pristine...
9.
Abashkin V, Pedziwiatr-Werbicka E, Gomez R, de la Mata F, Dzmitruk V, Shcharbin D, et al.
Pharmaceutics
. 2021 Oct;
13(10).
PMID: 34683842
Cancer is one of the most important problems of modern medicine. At the present time, gene therapy has been developed against cancer, which includes the delivery of anticancer small interfering...
10.
Terehova M, Dzmitruk V, Abashkin V, Kirakosyan G, Ghukasyan G, Bryszewska M, et al.
J Biotechnol
. 2021 Mar;
331:48-52.
PMID: 33727080
The interaction of nanoparticles (NP) with proteins (the so-called 'protein corona') is a huge challenge in attempting to apply them in personalized nanomedicine. We have analyzed the interaction between A)...